Rapid Dose Therapeutics Statistics
Total Valuation
RDTCF has a market cap or net worth of 18.71 million. The enterprise value is 20.59 million.
| Market Cap | 18.71M |
| Enterprise Value | 20.59M |
Important Dates
The last earnings date was Friday, June 27, 2025.
| Earnings Date | Jun 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 129.53M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +18.68% |
| Shares Change (QoQ) | +1.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 118.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.95 |
| PB Ratio | -5.19 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.50 |
| EV / Sales | 13.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -25.78 |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.26 |
| Interest Coverage | -3.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -148.14% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 80.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.18 |
| Inventory Turnover | 4.25 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +822.52% in the last 52 weeks. The beta is -0.21, so RDTCF's price volatility has been lower than the market average.
| Beta (5Y) | -0.21 |
| 52-Week Price Change | +822.52% |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | 0.29 |
| Relative Strength Index (RSI) | 50.37 |
| Average Volume (20 Days) | 29,470 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RDTCF had revenue of 1.44 million and -3.74 million in losses. Loss per share was -0.03.
| Revenue | 1.44M |
| Gross Profit | 817,708 |
| Operating Income | -2.89M |
| Pretax Income | -3.74M |
| Net Income | -3.74M |
| EBITDA | -2.74M |
| EBIT | -2.89M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 14,356 in cash and 1.81 million in debt, giving a net cash position of -1.79 million.
| Cash & Cash Equivalents | 14,356 |
| Total Debt | 1.81M |
| Net Cash | -1.79M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -3.61M |
| Book Value Per Share | -0.03 |
| Working Capital | -4.28M |
Cash Flow
In the last 12 months, operating cash flow was -794,646 and capital expenditures -3,977, giving a free cash flow of -798,623.
| Operating Cash Flow | -794,646 |
| Capital Expenditures | -3,977 |
| Free Cash Flow | -798,623 |
| FCF Per Share | n/a |
Margins
Gross margin is 56.59%, with operating and profit margins of -200.07% and -259.18%.
| Gross Margin | 56.59% |
| Operating Margin | -200.07% |
| Pretax Margin | -259.18% |
| Profit Margin | -259.18% |
| EBITDA Margin | -189.66% |
| EBIT Margin | -200.07% |
| FCF Margin | n/a |
Dividends & Yields
RDTCF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.68% |
| Shareholder Yield | n/a |
| Earnings Yield | -20.02% |
| FCF Yield | -4.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RDTCF has an Altman Z-Score of -47.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -47.62 |
| Piotroski F-Score | 3 |